Nicotine effects on prostaglandin-dependent gastric slow wave rhythmicity and antral motility in nonsmokers and smokers. 1996

K R Kohagen, and M S Kim, and W M McDonnell, and W D Chey, and C Owyang, and W L Hasler
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA.

OBJECTIVE Mechanisms of antral hypomotility with smoking are unknown. Slow wave disruption, which may be prostaglandin dependent, inhibits gastric motility. This study tested if nicotine reproduces motor effects of smoking and assessed the role of slow wave disruption in inducing hypomotility and the prostaglandin dependence of dysrhythmic responses. METHODS Electrogastrography and antroduodenal manometry were performed in 9 nonsmokers and 9 smokers during transdermal nicotine treatment (14 mg). Studies were repeated after administration of 150 mg indomethacin daily for 3 days to test prostaglandin requirements of nicotine responses. RESULTS Antral migrating motor complex periodicity and fasting and fed motility indices, not different in the groups under control conditions, decreased similarly in nonsmokers and smokers with nicotine. Tachygastria (> 4.5 cycle/min) increased from 2% +/- 2% to 16% +/- 3% of recording time, and arrhythmias (frequency instability index) increased from 0.5 +/- 0.1 to 1.1 +/- 0.2 cycle/min with nicotine in nonsmokers (P < 0.05), which normalized with indomethacin. Electrogastrography results were unchanged in smokers. CONCLUSIONS Nicotine evokes antral hypomotility in nonsmokers and smokers but evokes prostaglandin-dependent gastric dysrhythmias only in nonsmokers. Smokes show desensitization to nicotine-stimulated dysrhythmias. Thus, slow wave disruption is not essential to inhibit motor activity. This provides a model for the motor and myoelectric effects of smoking.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D008365 Manometry Measurement of the pressure or tension of liquids or gases with a manometer. Tonometry,Manometries
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011706 Pyloric Antrum The region between the sharp indentation at the lower third of the STOMACH (incisura angularis) and the junction of the PYLORUS with the DUODENUM. Pyloric antral glands contain mucus-secreting cells and gastrin-secreting endocrine cells (G CELLS). Antrum, Pyloric,Gastric Antrum,Antrum, Gastric,Antrums, Gastric,Antrums, Pyloric,Gastric Antrums,Pyloric Antrums
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005260 Female Females
D005769 Gastrointestinal Motility The motor activity of the GASTROINTESTINAL TRACT. Intestinal Motility,Gastrointestinal Motilities,Intestinal Motilities,Motilities, Gastrointestinal,Motilities, Intestinal,Motility, Gastrointestinal,Motility, Intestinal

Related Publications

K R Kohagen, and M S Kim, and W M McDonnell, and W D Chey, and C Owyang, and W L Hasler
August 1981, The American journal of physiology,
K R Kohagen, and M S Kim, and W M McDonnell, and W D Chey, and C Owyang, and W L Hasler
September 1990, Pharmacology, biochemistry, and behavior,
K R Kohagen, and M S Kim, and W M McDonnell, and W D Chey, and C Owyang, and W L Hasler
January 1994, Clinical pharmacology and therapeutics,
K R Kohagen, and M S Kim, and W M McDonnell, and W D Chey, and C Owyang, and W L Hasler
January 2005, Physiology & behavior,
K R Kohagen, and M S Kim, and W M McDonnell, and W D Chey, and C Owyang, and W L Hasler
January 1991, Psychopharmacology,
K R Kohagen, and M S Kim, and W M McDonnell, and W D Chey, and C Owyang, and W L Hasler
July 2006, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
K R Kohagen, and M S Kim, and W M McDonnell, and W D Chey, and C Owyang, and W L Hasler
January 1984, Scandinavian journal of gastroenterology. Supplement,
K R Kohagen, and M S Kim, and W M McDonnell, and W D Chey, and C Owyang, and W L Hasler
February 1986, The Journal of physiology,
K R Kohagen, and M S Kim, and W M McDonnell, and W D Chey, and C Owyang, and W L Hasler
March 1993, Clinical pharmacology and therapeutics,
K R Kohagen, and M S Kim, and W M McDonnell, and W D Chey, and C Owyang, and W L Hasler
January 1991, Psychopharmacology,
Copied contents to your clipboard!